The Food and Drug Administration requires drug companies to run studies investigating whether GLP-1s increase the risk of cardiovascular problems a mandate for all diabetes drugs
Lancet Title: Tirzepatide Once Weekly for the Treatment of Obesity in People With Type 2 Diabetes (Surmount-2): A Double-Blind, Randomised, Multicentre, Placebo-Controlled, Phase 3 Trial
And last month, a separate survey by Morning Consult and the Physicians Committee for Responsible Medicine found that 62% of Americans would rather make a dietary change than take an injectable weight-loss drug if they wanted to lose weight
If you're navigating metabolic health concerns, a qualified clinician is the right starting point
Remember: Wegovy works best with healthy eating and exercise
Despite substantial progress, the successful development of peptides as drugs still requires a number of limitations to be addressed, including short in vivo half-lives and poor membrane permeability